|
Vanderbilt Implementations of Atopic Dermatitis |
Atopic Dermatitis Algorithm |
Vanderbilt University |
Case, Control |
|
|
|
|
|
Vanderbilt Implementation- Adult- BioVU- Emerge subset |
Pneumonia- VUMC eMERGE v5.1 |
Vanderbilt University Medical Center |
Case, Control |
|
|
|
|
|
Vanderbilt Implementation of Heart Failure |
Heart Failure (HF) with Differentiation between Preserved and Reduced Ejection Fraction |
Vanderbilt University |
Case Only |
|
|
|
|
|
Vanderbilt Implementation of CHD |
MidSouth CDRN - Coronary Heart Disease Algorithm |
Vanderbilt University |
Case Only |
|
|
98% |
95% |
|
Vanderbilt Implementation of caMRSA |
caMRSA |
Vanderbilt University |
Case, Control |
262 |
2,313 |
|
|
|
Vanderbilt implementation |
Clostridium Difficile Colitis |
|
Case, Control |
|
|
100%, 100% |
|
|
Vanderbilt Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
|
Case, Control |
153 |
2,152 |
|
|
|
Vanderbilt evaluation for Diverticulosis |
Diverticulosis and Diverticulitis |
Vanderbilt University |
Case Only |
|
|
88% |
|
|
Vanderbilt CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Vanderbilt University |
Case, Control |
128 |
4,571 |
|
|
|
Validation on 75 RA patients |
Identification of Fibromyalgia Patients in a Rheumatoid Arthritis Cohort |
Vanderbilt University |
Case Only |
|
|
97% |
|
|
Validation of Asthma algorithm - Marshfield |
Asthma |
Marshfield Clinic |
Case, Control |
|
|
96%, 96% |
|
|
Validation of Asthma algorithm - Geisinger |
Asthma |
Geisinger |
Case, Control |
10 |
10 |
100%, 100% |
|
|
Validation of Asthma Algorithm |
Asthma |
CHOP |
Case, Control |
|
|
96%, 98% |
|
|
Validation of ACEi-induced cough algorithm |
ACE Inhibitor (ACE-I) induced cough |
Mayo Clinic |
Case, Control |
|
|
100%, 96% |
|
|
Validation |
Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) |
Geisinger |
Case Only |
|
|
|
|
|
Updated Geisinger Impl |
CAAD (Carotid Artery Atherosclerosis Disease) |
Geisinger |
Case, Control |
|
|
|
|
|
T2DM Implementation - Columbia |
Type 2 Diabetes Mellitus |
Columbia University |
Case, Control |
293 |
478 |
|
|
|
T2D Vanderbilt Implementation |
Type 2 Diabetes Mellitus |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
|
|
T2D Northwestern Implementation |
Type 2 Diabetes Mellitus |
Northwestern University |
Case, Control |
|
|
98%, 100% |
100%, 100% |
|
T2D Marshfield Implementation |
Type 2 Diabetes Mellitus |
Marshfield Clinic Research Foundation |
Case, Control |
|
|
99%, 98% |
100%, 98% |
|
Statins and MACE: request for lipids lab data sep2015 |
Statins and MACE |
GHRI/UW |
Case, Control |
|
|
|
|
|
Statins and MACE Marshfield Implementation |
Statins and MACE |
Marshfield Clinic Research Foundation |
Case Only |
50 |
|
100% |
100% |
|
Statin and MACE Mount Sinai Implementation |
Statins and MACE |
Mount Sinai |
Case Only |
52 |
25 |
96%, 100% |
100%, 100% |
|
Statin and MACE Implementation - Columbia |
Statins and MACE |
Columbia University |
Case, Control |
41 |
570 |
|
|
|
Sleep Apnea-Columbia |
Sleep Apnea Phenotype |
Columbia University |
Case Only |
|
|
|
|
